Tag: Cesca Therapeutics

April 24, 2018

Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has...
April 17, 2018

Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has...
March 23, 2018

Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017

Cesca Therapeutics (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced financial and operating...
March 15, 2018

Top 10 Stem Cell Companies On The NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
November 28, 2017

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

Cesca Therapeutics was awarded a new patent from the US Patent and Trademark Office.